Kalra Balkrishan 4
4 · Genpact LTD · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Kalra Balkrishan
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Shares
2025-03-13$27.65/sh+13,600$376,040→ 323,846 total - Sale
Common Shares
2025-03-13$48.89/sh−13,600$664,904→ 310,246 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-03-13−13,600→ 42,800 totalExercise: $27.65Exp: 2026-03-31→ Common Shares (13,600 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
- [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $48.70 to $49.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.